Impact of Long-term Ivermectin Treatment on Allergic Reactions in Children
Author Information
Author(s): P. Endara, M. Vaca, M. E. Chico, S. Erazo, G. Oviedo, I. Quinzo, A. Rodriguez, R. Lovato, A.-L. Moncayo, M. L. Barreto, L. C. Rodrigues, P. J. Cooper
Primary Institution: Colegio de Ciencias de la Salud, Universidad San Francisco de Quito
Hypothesis
Does long-term anthelmintic treatment with ivermectin increase the prevalence of allergic diseases in children?
Conclusion
Long-term periodic treatments with ivermectin were associated with an increased prevalence of allergen skin test reactivity and recent eczema symptoms in children.
Supporting Evidence
- The prevalence of allergen skin test reactivity was double in treated communities compared to untreated ones.
- Treated children had a higher prevalence of recent eczema symptoms.
- Long-term ivermectin treatment was associated with a reduced prevalence of Trichuris trichiura among treated children.
Takeaway
Giving children medicine to treat worms for a long time might make them more likely to have skin allergies and rashes.
Methodology
The study compared allergen skin test reactivity and allergic symptoms between children in treated and untreated communities over 15–17 years.
Potential Biases
Potential biases include observation bias and recall bias due to differences in maternal education levels between treatment groups.
Limitations
The study lacked historical data on allergy prevalence before ivermectin treatment began, which could affect the interpretation of results.
Participant Demographics
Children aged 6–16 years, predominantly Afro-Ecuadorian, from rural communities in Ecuador.
Statistical Information
P-Value
P<0.0001
Confidence Interval
95% CI 1.50–2.94
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website